The AstraZeneca PLC (AZN) revenue growth is 18.0%, which is lower than the industry median of 5.2% and the 5-year historical average of 17.4%.
The AstraZeneca PLC (AZN) operating income growth is 22.1%, compared to the industry median of 10.0% and the 5-year historical average of 606.7%.
The AstraZeneca PLC (AZN) EPS growth is (6.3%), compared to the industry median of (6.3%) and the 5-year historical average of 72.7%.
The AstraZeneca PLC (AZN) Free Cash Flow growth is 10.8%, compared to the industry median of 10.8% and the 5-year historical average of 70.8%.